Alibaba Health Information Technology Limited (HKG:0241)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.260
0.00 (0.00%)
Aug 21, 2026, 4:08 PM HKT

HKG:0241 Cash Flow Statement

Millions CNY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,9361,432883.48535.65-265.56
Depreciation & Amortization
53.2457.6153.6863.7260.58
Loss (Gain) From Sale of Assets
-8.96-0.62-0.531.24-0.14
Asset Writedown & Restructuring Costs
5.52----
Loss (Gain) From Sale of Investments
176.07410.62283.44-112.24-542.1
Loss (Gain) on Equity Investments
-2.1764.665.93-11.3845.62
Stock-Based Compensation
162.12224.54266.06308.89408.1
Provision & Write-off of Bad Debts
0.986.215.141.820.13
Other Operating Activities
-192.57-232.43-77.3636.1163.63
Change in Accounts Receivable
-214.34-273.59-211.49-64.63-201.98
Change in Inventory
-564.27-107.88614.1-711.69-129.2
Change in Accounts Payable
177.39-498.19-363.48186.71959.57
Change in Unearned Revenue
157.39140.4159.62234.3970.1
Change in Other Net Operating Assets
-449.93171.28-436.26-212.91-44.39
Operating Cash Flow
1,2371,3951,080255.69424.36
Operating Cash Flow Growth
-11.36%29.19%322.32%-39.75%-57.96%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-8.99-18.89-22.77-5.61-14.93
Sale of Property, Plant & Equipment
3.515.970.750.411.86
Cash Acquisitions
---131.03-77.33-815.6
Divestitures
10.11----
Sale (Purchase) of Intangibles
--0.01-0.01-0.31-0.19
Investment in Securities
1,703-2,943-4,857-512.482,799
Other Investing Activities
312.99359.41115.8947.08-112.09
Investing Cash Flow
2,021-2,596-4,881-532.441,872

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Repaid
-24.98-38.09-39.93-42.59-47.01
Total Debt Repaid
-24.98-38.09-39.93-42.59-47.01
Net Debt Issued (Repaid)
-24.98-38.09-39.93-42.59-47.01
Issuance of Common Stock
10.764.590.8812.899.69
Repurchase of Common Stock
--39.93-104.57-81.58-16.52
Other Financing Activities
-0.92-1,839--4.79
Financing Cash Flow
-14.22-72.52-1,982-111.28-58.63

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
-27.642.0936.78283.45-148.89
Net Cash Flow
3,216-1,272-5,747-104.582,089

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
1,2281,3761,057250.08409.43
Free Cash Flow Growth
-10.79%30.19%322.69%-38.92%-58.74%
Free Cash Flow Margin
3.58%4.50%3.91%0.93%1.99%
Free Cash Flow Per Share
0.080.090.070.020.03
Levered Free Cash Flow
599.96693.25318.76-19.58700.89
Unlevered Free Cash Flow
600.83694.88322.49-15.93703.27

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
1.42.615.975.833.82
Cash Income Tax Paid
348.02106.9340.6143.1145.34
Change in Working Capital
-893.76-567.97-337.52-568.13654.1